Financing SCIEX LC/MS/MS instrumentation is a critical decision for high-volume clinical diagnostics and CROs. Standardizing on SCIEX triple quad platforms—specifically the SCIEX 6500+ and 7500 systems—is an industry gold standard for sensitivity. However, acquiring a brand-new fleet requires significant upfront capital that can jeopardize the very growth the equipment is meant to support.
By shifting from a purchase model to a science-native leasing model, you preserve your runway and keep your capital focused on value-building activities like specialized staffing and facility expansion.
At Bold View Capital, we offer specialized programs designed to turn financing SCIEX LC/MS/MS systems into a strategic advantage for your lab.
1. The $1 Buyout Capital Lease (Full Ownership)
This is considered one of the industry standards for labs that want the tax benefits of ownership without the immediate cash drain.
- The Structure: You pay for the equipment over a set term, typically 36–60 months.
- The Buyout: At the end of the lease, you own the SCIEX triple quad systems outright for exactly $1.
- The Benefit: This structure allows you to preserve your venture capital or operating cash for high-value milestones.
2. 0% Financing SCIEX LC/MS/MS Over 12 Months
For labs with strong short-term cash visibility but a mandate to preserve their “runway,” we offer short-term interest-free programs.
- The Structure: Spread the cost of your SCIEX Triple Quad 6500+ system over 12 equal monthly installments.
- The Benefit: You avoid the “Throughput Trap” where you pay for 100% of the hardware months before your clinical contracts start generating revenue.
3. Rentals-with-Equity: The Flexible Path to Ownership
Perfect for growing CROs scaling to support multi-site Phase III trials where the long-term volume is projected but not yet “on the books”.
- The Structure: Start with a flexible rental agreement to get SCIEX 7500+ systems on the bench and validated immediately.
- The Equity Credit: A portion of every monthly rental payment is credited toward the eventual purchase price.
- The Benefit: This provides the “speed of science”—allowing you to pivot if a trial timeline shifts while still building a path toward full asset ownership.
4. Sale Leasebacks: Unlock Existing Lab Equity
If your lab already owns SCIEX instrumentation outright but needs immediate liquidity for a facility expansion or a new project, a sale leaseback is the answer.
- The Structure: Bold View Capital purchases your existing, in-place SCIEX fleet at its current value and leases it back to you.
- The Benefit: You get an immediate infusion of cash while keeping the instruments on your bench, ensuring no interruption to your clinical workflows.
Why Bold View? Rooted in Science, Built for Biotech
Generic lenders look at a mass spec and see a high-risk “black box.” At Bold View Capital, we are operators who speak the language of science, and make financing SCIEX LC/MS/MS easy and straightforward.
We understand the difference between a Triple Quad and a QTRAP. We know why a high-throughput lab needs the sensitivity of a 6500+ to meet regulatory requirements.
Because we understand the inherent value and reliability of SCIEX instrumentation, we offer:
- Science-Native Underwriting: We look at your contracts, your data, and your team—not just a generic credit score.
- Proven Partnerships: We have deep relationships with analytical instrumentation vendors, ensuring a worry-free procurement and installation process.
- Fast Approvals: We move at the “speed of science,” providing the quick decisions required to keep your clinical projects on schedule.
If your lab is interested in financing SCIEX LC/MS/MS systems, reach out to a Bold View Capital team member today.
Frequently Asked Questions
1. What is the difference between a Capital Lease and a traditional bank loan?
Traditional banks often require rigid monthly payments and a high credit score based on general business metrics. At Bold View Capital, our financing for SCIEX LC/MS/MS is “science-native,” meaning we look at your clinical contracts and the specific value of the SCIEX 6500+ or 7500 LC/MS/MS systems. A Capital Lease also provides a clear path to ownership for $1 at the end of the term. Learn why you should work with a lab equipment financing partner that gets the science.
2. How does the “Rentals-with-Equity” program help my lab?
With a rentals-with-equity, you get the SCIEX LC/MS/MS on your bench immediately. A portion of every rental payment is credited toward the eventual purchase, allowing you to build equity while maintaining the flexibility to pivot if trial timelines shift.
3. How fast can I get approval for my SCIEX fleet?
Because we understand the technology and market for SCIEX triple quads, we move at the “speed of science”. We offer fast approvals based on your specific clinical milestones and team expertise rather than just a generic credit score.
